The filing for the resale of a significant number of shares by Autolus Therapeutics could lead to increased liquidity in the market for AUTL shares. However, this action might also result in dilution of the value of existing shares, which typically has a negative short-term impact on the stock price. The confidence in this analysis is high due to the direct relationship between share dilution and stock price performance, although market reactions can vary.